Drug Protocol Reduces Risk of HIV Infection

An anti-HIV drug combination, Truvada, plus prevention strategies can reduce the risk of healthy adolescents at risk for acquiring HIV. The Food and Drug Administration has approved the drug combination for HIV prevention treatment for adolescents 15 years and older. 

The research for this pre-exposure prophylaxis, or PrEP, was supported by Westat. Westat provided full-service support for this study through the Adolescent Trials Network for HIV/AIDS Interventions (ATN) – ATN  protocol 113.  The Eunice Kennedy Shriver National Institute of Child Health and Human Development funds ATN research.

Learn more about Westat’s work supporting ATN.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
Client List
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Internal Revenue Service
National Science Foundation
Social Security Administration
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
Georgia Department of Transportation
Maryland Cancer Registry
Michigan Department of Health and Human Services
Texas Education Agency
Baltimore Metropolitan Council
Chicago Metropolitan Agency for Planning
DC Public Schools
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
AAA Foundation for Traffic Safety
ClearWay Minnesota
Robert Wood Johnson Foundation
Teach for America
The Verizon Foundation
The Johns Hopkins University
University of Denver
University of Maryland Baltimore Campus
University of Michigan
SiriusXM
Toyota
U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
The National Institutes of Health

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity, or any other protected status under applicable law. Notices to Employees & Applicants.